Case Name |
Date Filed |
Judge |
Drug |
Patent No(s). |
United Therapeutics Corp. v. ANI Pharms., Inc., 21-0489 (D. Del.) |
Apr. 1, 2021 |
Hon. Richard G. Andrews |
Orenitram® (treprostinil extended-release tablets) |
7,417,070
7,544,713
8,252,839
8,349,892
8,410,169
8,747,897
9,050,311
9,278,901
9,393,203
9,422,223
9,593,066
9,604,901 |
EPI Health, LLC v. Perrigo UK Finco Ltd. Partnership, 21-0498 (D. Del.) |
Apr. 5, 2021 |
Hon. Colm F. Connolly |
Rhofade® (oxymetazoline HCl cream) |
7,812,049
8,420,688
8,815,929
8,883,838
9,974,773
10,335,391
10,751,325 |
Azurity Pharms., Inc. v. Amneal Pharms. LLC, 21-8717 (D.N.J.) |
Apr. 8, 2021 |
Hon. Freda L. Wolfson |
Katerzia® (amlodipine oral suspension) |
10,695,329
10,799,453
10,894,039
10,952,998 |
Purdue Pharma L.P. v. Collegium Pharm., Inc., 21-10598 (D. Mass.) |
Apr. 9, 2021 |
Hon. F. Dennis Saylor, IV |
OxyContin® (oxycodone HCl extended-release tablets) Xtampza® ER (oxycodone extended-release capsules) |
10,407,434 |
Boehringer Ingelheim Pharms. Inc. v. Lupin Ltd., 21-0530 (D. Del.) |
Apr. 13, 2021 |
Hon. Colm F. Connolly |
Trijardy® XR (empagliflozin / linagliptin / metformin HCl extended-release tablets) |
8,551,957
9,155,705
9,415,016
9,949,998
10,022,379
10,258,637
10,406,172 |
Duchesnay Inc. v. Hetero Labs Ltd., 21-0538 (D. Del.) |
Apr. 14, 2021 |
Hon. Leonard P. Stark |
Osphena® (ospemifene tablets) |
8,642,079 |
CMP Development, LLC v. Amneal Pharms. LLC, 21-0549 (D. Del.) |
Apr. 16, 2021 |
Hon. Maryellen Noreika |
CaroSpir® (spironolactone oral suspension) |
9,757,394
10,493,083
10,624,906
10,660,907
10,888,570 |
AstraZeneca AB v. Zydus Pharms. (USA), Inc., 21-0550 (D. Del.) |
Apr. 16, 2021 |
Hon. Richard G. Andrews |
Tagrisso® (osimertinib mesylate tablets) |
10,183,020 |
Bayer Pharma AG v. Accord Healthcare Inc., 21-0566 (D. Del.) |
Apr. 22, 2021 |
Hon. Richard G. Andrews |
Xarelto® (rivaroxaban tablets) |
10,828,310 |
Bausch Health Ireland Ltd. v. MSN Labs. Private Ltd., 21-10057 (D.N.J.) |
Apr. 22, 2021 |
Hon. Stanley R. Chesler |
Trulance® (plecanatide tablets) |
7,041,786
7,799,897
8,637,451
9,610,321
9,616,097
9,919,024
9,925,231
10,011,637 |
Otsuka Pharm. Co., Ltd. v. Sandoz Inc., 21-0580 (D. Del.) |
Apr. 26, 2021 |
Hon. Leonard P. Stark |
Rexulti® (brexpiprazole tablets) |
RE48,059 |
Celgene Corp. v. Hikma Pharms. USA, Inc., 21-10398 (D.N.J.) |
Apr. 28, 2021 |
Hon. Susan D. Wigenton |
Revlimid® (lenalidomide capsules) |
7,189,740
7,465,800
7,855,217
7,968,569
8,404,717
8,530,498
8,648,095
9,056,120
9,101,621
9,101,622 |
Bausch Health Ireland Ltd. v. Mylan Labs. Ltd., 21-10403 (D.N.J.) |
Apr. 28, 2021 |
Hon. Stanley R. Chesler |
Trulance® (plecanatide tablets) |
7,041,786
7,799,897
8,637,451
9,610,321
9,616,097
9,919,024
9,925,231
10,011,637 |
Bausch Health Ireland Ltd. v. Mylan Labs. Ltd., 21-0611 (D. Del.) |
Apr. 29, 2021 |
Hon. Leonard P. Stark |
Trulance® (plecanatide tablets) |
7,041,786
7,799,897
8,637,451
9,610,321
9,616,097
9,919,024
9,925,231
10,011,637 |
Mayne Pharma LLC v. Perrigo Israel Pharms. Ltd., 21-0612 (D. Del.) |
Apr. 29, 2021 |
Hon. Colm F. Connolly |
Lexette® (halobetasol propionate topical foam) |
10,857,159 |
Bausch Health Ireland Ltd. v. Mylan Labs. Ltd., 21-0573 (W.D. Pa.) |
Apr. 30, 2021 |
Hon. W. Scott Hardy |
Trulance® (plecanatide tablets) |
7,041,786
7,799,897
8,637,451
9,610,321
9,616,097
9,919,024
9,925,231
10,011,637 |
Novartis Pharms. Corp. v. Handa Neuroscience, LLC, 21-0645 (D. Del.) |
4-May-21 |
Hon. Leonard P. Stark |
Gilenya® (fingolimod tablets) |
9,187,405
10,543,179 |
Novartis Pharms. Corp. v. Handa Neuroscience, LLC, 21-3397 (N.D. Ca.) |
6-May-21 |
Hon. Edward J. Davila |
Gilenya® (fingolimod tablets) |
9,187,405
10,543,179 |
Amgen Inc. v. Aurobindo Pharma Ltd., 21-0662 (D. Del.) |
6-May-21 |
Hon. Maryellen Noreika |
Parsabiv® (etelcalcetide for injection) |
9,820,938
10,344,765 |
Astellas Pharma Inc. v. Sandoz Inc., 21-0664 (D. Del.) |
7-May-21 |
Hon. Joseph F. Bataillon |
Myrbetriq® (mirabegron extended-release tablets) |
10,842,780 |
Astellas US LLC v. American Regent, Inc., 21-0671 (D. Del.) |
7-May-21 |
Hon. Colm F. Connolly |
Lexiscan® (regadenoson for injection) |
8,106,183
RE47,301
8,524,883 |
Jazz Pharms., Inc. v. Avadel Pharms. PLC, 21-0691 (D. Del.) |
12-May-21 |
Hon. Maryellen Noreika |
Xyrem® (sodium oxybate oral solution) |
8,731,963
10,758,488
10,813,885
10,959,956
10,966,931 |
Teva Pharms. Int’l GmbH v. Dr. Reddy’s Labs., Ltd., 21-0695 (D. Del.) |
13-May-21 |
Hon. Colm F. Connolly |
Bendeka® (bendamustine HCl for injection) |
8,609,707
9,265,831
9,572,796
9,572,797
9,034,908
9,144,568
9,572,887
9,597,397
9,597,398
9,597,399
9,000,021
9,579,384
10,010,533
10,052,385 |
Melinta Therapeutics, LLC v. Nexus Pharms., Inc., 21-11198 (D.N.J.) |
13-May-21 |
Hon. Brian R. Martinotti |
Minocin® (minocycline for injection) |
9,278,105
9,084,802 |
Melinta Therapeutics, LLC v. Nexus Pharms., Inc., 21-2636 (N.D. Ill.) |
14-May-21 |
Hon. John F. Kness |
Minocin® (minocycline for injection) |
9,278,105
9,084,802 |
Bausch Health Ireland Ltd. v. Lupin Ltd., 21-11258 (D.N.J.) |
14-May-21 |
Hon. Renee Marie Bumb |
Plenvu® (PEG 3350 / sodium ascorbate / sodium sulfate / ascorbic acid / sodium chloride / potassium chloride oral solution) |
10,918,723 |
Celgene Corp. v. Biocon Pharma Ltd., 21-11261 (D.N.J.) |
14-May-21 |
Hon. Susan D. Wigenton |
Revlimid® (lenalidomide capsules) |
7,189,740
7,465,800
7,855,217
7,968,569
8,404,717
8,530,498
8,648,095
9,056,120
9,101,621
9,101,622 |
Amgen Inc. v. MSN Labs. Private Ltd., 21-0712 (D. Del.) |
19-May-21 |
Hon. Maryellen Noreika |
Parsabiv® (etelcalcetide for injection) |
8,377,880
8,999,932
9,278,995
9,701,712
9,820,938
10,344,765 |
Bayer Pharma AG v. Dr. Reddy’s Labs., Inc., 21-0732 (D. Del.) |
24-May-21 |
Hon. Richard G. Andrews |
Xarelto® (rivaroxaban tablets) |
10,828,310 |
Almirall, LLC v. Acrux DDS Pty. Ltd., 21-11948 (D.N.J.) |
28-May-21 |
Hon. Madeline Cox Arleo |
Aczone® (dapsone gel) |
9,517,219 |
Supernus Pharms., Inc. v. Riconpharma LLC, 21-12133 (D.N.J.) |
3-Jun-21 |
Hon. Freda L. Wolfson |
Oxtellar XR® (oxcarbazepine extended-release tablets) |
7,722,898
7,910,131
8,617,600
8,821,930
9,119,791
9,351,975
9,370,525
9,855,278
10,220,042 |
Merck Sharp & Dohme Corp. v. Alkem Labs. Ltd., 21-0824 (D. Del.) |
4-Jun-21 |
Hon. Richard G. Andrews |
Januvia® (sitagliptin phosphate tablets) |
7,326,708 |
Taiho Pharm. Co., Ltd. v. Accord Healthcare Inc., 21-0838 (D. Del.) |
9-Jun-21 |
Hon. Colm F. Connolly |
Lonsurf® (tipiracil HCl / trifluridine tablets) |
10,960,004 |
Newron Pharms. S.p.A. v. Aurobindo Pharma Ltd., 21-0843 (D. Del.) |
10-Jun-21 |
Hon. Richard G. Andrews |
Xadago® (safinamide tablets) |
8,076,515
8,278,485
8,283,380 |
Pfizer Inc. v. MSN Pharms. Inc., 21-0858 (D. Del.) |
15-Jun-21 |
Hon. Colm F. Connolly |
Ibrance® (palbociclib tablets) |
10,723,730 |
Exelixis, Inc. v. Teva Pharm. Indus. Ltd., 21-0871 (D. Del.) |
17-Jun-21 |
Hon. Richard G. Andrews |
Cabometyx® (cabozantinib s-malate tablets) |
9,724,342
10,039,757
10,034,873 |
Novartis Pharms. Corp. v. Fresenius Kabi USA, LLC, 21-0870 (D. Del.) |
17-Jun-21 |
Hon. Leonard P. Stark |
Kisqali® (ribociclib tablets) Kisqali® Femara® Co-pack (ribociclib / letrozole tablets) |
8,324,225
8,415,355
8,685,980
8,962,630
9,193,732
9,416,136
9,868,739
10,799,506 |
Apotex Inc. v. Pfizer Inc., IPR2021-01132 (PTAB) |
17-Jun-21 |
N/A |
Chantix® (varenicline tartrate tablets) |
6,890,927 |
AstraZeneca AB v. Alembic Pharms. Ltd., 21-0875 (D. Del.) |
18-Jun-21 |
Hon. Richard G. Andrews |
Brilinta® (ticagrelor tablets) |
8,425,934
10,300,065 |
TherapeuticsMD, Inc. v. Teva Pharms. USA, Inc., 21-12794 (D.N.J.) |
21-Jun-21 |
Hon. Brian R. Martinotti |
Imvexxy® (estradiol vaginal inserts) |
10,888,516 |
Tris Pharma, Inc. v. Ascent Pharms., Inc., 21-12867 (D.N.J.) |
22-Jun-21 |
Hon. Kevin McNulty |
QuilliChew ER® (methylphenidate HCl extended-release chewable tablets) |
8,999,386
9,295,642
9,545,399
9,844,544 |
Azurity Pharms., Inc. v. Bionpharma Inc., 21-12870 (D.N.J.) |
22-Jun-21 |
Hon. Michael A. Shipp |
Epaned® (enalapril maleate oral solution) |
11,040,023 |
Otsuka Pharm. Co., Ltd. v. Lupin Ltd., 21-0900 (D. Del.) |
23-Jun-21 |
Hon. Richard G. Andrews |
Jynarque® (tolvaptan tablets) |
8,501,730
10,905,694 |
Celgene Corp. v. Torrent Pharms. Ltd., 21-12927 (D.N.J.) |
23-Jun-21 |
Hon. Susan D. Wigenton |
Revlimid® (lenalidomide capsules) |
7,189,740
7,465,800
7,855,217
7,968,569
8,404,717
8,530,498
8,648,095
9,056,120
9,101,621
9,101,622 |
Takeda Pharms. America, Inc. v. Apotex, Inc., 21-12998 (D.N.J.) |
25-Jun-21 |
Hon. Kevin McNulty |
Iclusig® (ponatinib HCl tablets) |
9,493,470 |
Pfizer Inc. v. Qilu Pharm. Co., Ltd., 21-0929 (D. Del.) |
29-Jun-21 |
Hon. Colm F. Connolly |
Ibrance® (palbociclib capsules) |
10,723,730 |
Teva Pharms. Int’l GmbH v. Accord Healthcare Inc., 21-0952 (D. Del.) |
29-Jun-21 |
Hon. Colm F. Connolly |
Bendeka® (bendamustine HCl injection) |
8,609,707
9,265,831
9,572,796
9,572,797
9,034,908
9,144,568
9,572,887
9,597,397
9,597,398
9,597,399
9,000,021
9,579,384
10,010,533
10,052,385 |
Amphastar Pharms. Inc. v. Eli Lilly and Co., 21-1922 (S.D. Ind.) |
29-Jun-21 |
Hon. Richard L. Young |
Forteo® (teriparatide injection) |
7,517,334 |
Novartis Pharms. Corp. v. Micro Labs Ltd., 21-0969 (D. Del.) |
30-Jun-21 |
Hon. Leonard P. Stark |
Xiidra® (lifitegrast ophthalmic solution) |
7,314,938
7,745,460
7,790,743
7,928,122
9,216,174
10,124,000
8,084,047
8,592,450
8,168,655
8,367,701
9,447,077
8,927,574
9,353,088
9,890,141
9,085,553 |
Astellas Pharma Inc. v. Sandoz Inc., 21-13177 (D.N.J.) |
30-Jun-21 |
Hon. John Michael Vazquez |
Xtandi® (enzalutamide tablets) |
7,709,517
8,183,274 |